Patent · US Active

Methods for the treatment of nonalcoholic steatohepatitis

US9193971B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITE DE PARIS DESCARTES · FR

Inventors

Alain Tedgui · Paris, FR
Xavier Loyer · Paris, FR
Pierre-Emmanuel Rautou · Paris, FR

Key dates

Filing date	Apr 10, 2013
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Apr 10, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/15042
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the treatment of nonalcoholic steatohepatitis (NASH), in particular to a compound that inhibits miR-21 expression for use in the treatment of nonalcoholic steatohepatitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.